DUXAP8 and neoplasm: DUXAP8, which is overexpressed in > 60% of high-risk NB tumors, accelerates tumor progression via dual mechanisms: sequestering miR-29 to derepress NOL4L-mediated cell cycle activation and enhancing metastatic potential through TWIST1 stabilization.